JP2005206503A5 - - Google Patents

Download PDF

Info

Publication number
JP2005206503A5
JP2005206503A5 JP2004013692A JP2004013692A JP2005206503A5 JP 2005206503 A5 JP2005206503 A5 JP 2005206503A5 JP 2004013692 A JP2004013692 A JP 2004013692A JP 2004013692 A JP2004013692 A JP 2004013692A JP 2005206503 A5 JP2005206503 A5 JP 2005206503A5
Authority
JP
Japan
Prior art keywords
preferable
mpa
salt solvent
solvent
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004013692A
Other languages
Japanese (ja)
Other versions
JP2005206503A (en
JP4324669B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2004013692A priority Critical patent/JP4324669B2/en
Priority claimed from JP2004013692A external-priority patent/JP4324669B2/en
Publication of JP2005206503A publication Critical patent/JP2005206503A/en
Publication of JP2005206503A5 publication Critical patent/JP2005206503A5/ja
Application granted granted Critical
Publication of JP4324669B2 publication Critical patent/JP4324669B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

本発明方法においては、反応媒体として、テトラアルキルアンモニウム塩系溶媒、テトラアルキルホスホニウム塩系溶媒、N‐メチル,N´‐C4〜C8アルキル‐イミダゾリウム塩系溶媒、N‐アルキルピリジニウム塩系溶媒を用いるのが好ましい。
また、原料の環状アミンとしては、アジリジン類、アゼチジン類、ピロリジン類、ピペリジン類を用いるのがよく、中でもアジリジン類、アゼチジン類を用いるのが、所期の効果をより良好に奏しうるので好ましい。
更に、反応にはオートクレーブ等の耐圧容器を用いるのが好ましく、環状ウレタンを良好な収率で得るには、ハロゲン、中でもヨウ素を触媒とするのがよい。
また、反応条件については、反応温度を0℃〜200℃、より好ましくは二酸化炭素を超臨界状態下とする、31.1℃〜200℃、圧力を常圧〜100MPa、より好ましくは二酸化炭素を超臨界状態下とする、7.38MPa〜100MPaの範囲とするのが好ましい。
In the method of the present invention, tetraalkylammonium salt solvent, tetraalkylphosphonium salt solvent, N-methyl, N′-C 4 -C 8 alkyl-imidazolium salt solvent, N-alkylpyridinium salt solvent are used as the reaction medium. It is preferable to use a solvent.
Further, as the raw material cyclic amine, aziridines, azetidines, pyrrolidines, and piperidines are preferably used, and among them, aziridines and azetidines are preferably used because the desired effects can be further improved.
Furthermore, it is preferable to use a pressure vessel such as an autoclave for the reaction. In order to obtain cyclic urethane in a good yield, it is preferable to use halogen, especially iodine as a catalyst.
Regarding the reaction conditions, the reaction temperature is 0 ° C. to 200 ° C., more preferably 31.1 ° C. to 200 ° C. with carbon dioxide in a supercritical state, the pressure is atmospheric pressure to 100 MPa, more preferably carbon dioxide. It is preferable to be in the range of 7.38 MPa to 100 MPa under the supercritical state.

JP2004013692A 2004-01-21 2004-01-21 Method for producing cyclic urethane Expired - Lifetime JP4324669B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004013692A JP4324669B2 (en) 2004-01-21 2004-01-21 Method for producing cyclic urethane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004013692A JP4324669B2 (en) 2004-01-21 2004-01-21 Method for producing cyclic urethane

Publications (3)

Publication Number Publication Date
JP2005206503A JP2005206503A (en) 2005-08-04
JP2005206503A5 true JP2005206503A5 (en) 2007-05-17
JP4324669B2 JP4324669B2 (en) 2009-09-02

Family

ID=34899681

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004013692A Expired - Lifetime JP4324669B2 (en) 2004-01-21 2004-01-21 Method for producing cyclic urethane

Country Status (1)

Country Link
JP (1) JP4324669B2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8835426B2 (en) 2007-02-26 2014-09-16 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
EP2183228B1 (en) 2007-07-26 2014-08-20 Vitae Pharmaceuticals, Inc. CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1
CA2708303A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
JP5490020B2 (en) 2008-01-24 2014-05-14 ヴァイティー ファーマシューティカルズ,インコーポレイテッド Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1
WO2009102428A2 (en) 2008-02-11 2009-08-20 Vitae Pharmaceuticals, Inc. 1,3-OXAZEPAN-2-ONE AND 1,3-DIAZEPAN-2-ONE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
WO2009102460A2 (en) 2008-02-15 2009-08-20 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2723039A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2291373B1 (en) 2008-05-01 2013-09-11 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5301563B2 (en) 2008-05-01 2013-09-25 ヴァイティー ファーマシューティカルズ,インコーポレイテッド Cyclic inhibitor of 11β-hydroxysteroid dehydrogenase 1
EP2291370B1 (en) 2008-05-01 2013-11-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
NZ590495A (en) 2008-07-25 2012-10-26 Vitae Pharmaceuticals Inc Dihydropyridin-phenyl-3-oxazinan-2-ones as inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW201016691A (en) 2008-07-25 2010-05-01 Boehringer Ingelheim Int Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2744946A1 (en) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
UA109255C2 (en) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
EP2448928B1 (en) 2009-07-01 2014-08-13 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
KR101102537B1 (en) 2009-07-31 2012-01-04 재단법인 포항산업과학연구원 Preparing method of dialkyl carbonate
US8933072B2 (en) 2010-06-16 2015-01-13 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
JP5813106B2 (en) 2010-06-25 2015-11-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Azaspirohexanone as an inhibitor of 11-β-HSD1 for the treatment of metabolic disorders
CA2813671A1 (en) 2010-11-02 2012-05-10 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders
CN108554456B (en) * 2016-09-20 2021-02-12 苏州大学 Application of rare earth imidazolium salt compound as catalyst

Similar Documents

Publication Publication Date Title
JP2005206503A5 (en)
ATE488494T1 (en) SEPARATION OF A MIXTURE OF HYDROGEN CHLORIDE AND PHOSGENE
JP2009538810A5 (en)
CA2660188A1 (en) Continuous methods and apparatus of functionalizing carbon nanotube
JP2008540615A5 (en)
JP4324669B2 (en) Method for producing cyclic urethane
JP2010508285A5 (en)
JP2003503383A5 (en)
Yu et al. Highly efficient bifunctional organocatalysts for the asymmetric Michael addition of ketones to nitroolefins
NO20080658L (en) Process for recovering a polymer from a liquid medium
WO2008103366A4 (en) Catalytic deamination for carprolactam production
ATE413913T1 (en) MEMBRANE FOR THE SEPARATION OF CO2 AND PRODUCTION PROCESS THEREOF
WO2009090179A3 (en) Method for the production of cycloaliphatic amines
Richelle et al. A One‐Pot “Triple‐C” Multicyclization Methodology for the Synthesis of Highly Constrained Isomerically Pure Tetracyclic Peptides
WO2005016880A1 (en) PROCESS FOR PRODUCTION OF cis-4-FLUORO-L-PROLINE DERIVATIVES
WO2008109243A3 (en) Gas clathrate hydrate compositions, synthesis and use
IL182831A0 (en) Method for the production of phthalic dichloride
PT1808430E (en) Method for producing light-coloured isocyanates
DE602005024278D1 (en) PREPARATION OF ULTRAREINE POLYMERIC OBJECTS
JP2007521013A5 (en)
WO2007134860A3 (en) Method for producing chlorine from hydrogen chloride and oxygen
CN107868022A (en) The preparation technology of tetrabutyl urea
JP2011506528A5 (en)
JP2008163025A (en) Process for preparing 2-aminomethylpiperidine
MX2011012946A (en) Rubber granulate conversion process for producing a semi-active carbonized substance and a plasticizer.